New drug combo aims to stop deadly brain cancer relapse in older patients
Disease control
Recruiting now
This study tests whether a combination of two drugs (lenalidomide and rituximab) can keep primary CNS lymphoma from coming back after initial treatment. It is for patients who cannot have a stem cell transplant, often due to age or health. The goal is to improve how long people l…
Phase: PHASE2 • Sponsor: Kim, Seok Jin • Aim: Disease control
Last updated May 05, 2026 11:52 UTC